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1. Introduction 
The pressorhormone angiotensin II, a linear octa- 
peptide of the sequence Asp-Arg-Val-Tyr-!&-His- 
Pro-Phe has been the subject of numerous conforma- 
tional analysis studies, most of which have centered on 
the backbone conformation [l-S]. Among the tech- 
niques employed, circular dichroism has advanced our 
understanding of angiotensin’s conformational behav- 
iour the most (see [6] and [7] for reviews on the 
subject). A universally accepted model of the peptide 
conformation, however, has not yet emerged. Although 
NH-C,H coupling constants measured at pH 2.5 by 
Marshall et al. [8] were inconclusive regarding the 
backbone structure, circular dichroism studies by 
Fermandjian et al. [9] , ’ H-a H exchange by Printz et 
al. [10],and1Handi9FNMRtitrations [l,ll],point- 
ed nevertheless to the existence of a certain preferred 
conformation of angiotensin II even in aqueous solu- 
tion. Circular dichroism is a useful tool to observe con- 
formational changes in peptides. As angiotensin II con- 
tains phenylalanine and tyrosine, one can follow the 
effects of pH in the two spectral regions, the so called 
* To whom correspondence should be adressed. .: 
**Abbreviations: (A II): angIotensin II. CD: circular dichroism. 
NMR: nuclear magnetic resonance. 
peptide region between 250 and 180 nm as well as the 
aromatic region from 320 to 250 nm. Here we report 
the preliminary results for the aromatic region obtain- 
ed during a titration of angiotensin II and several of 
its structural analogues. It appears that in angiotensin 
II the tyrosine side chain is preferentially oriented, 
being subjected to the influences both of the imme- 
diately preceding amino acid residue and of the histi- 
dine side chain. 
2. Materials and methods 
The peptides Asn’ -(A II)** and D-His6 -(A II) are a 
gift from Dr Riniker (Ciba-Geigy, Basel). The peptides 
Ile’ -(A II), P-Asp’ -(A II), Ala4 -(A II), Ala6-(A II), 
Iles-(A II), Pro3-(A II), 4-8 pentapeptide-(A II) and 
1-6 hexapeptide-(A II) have been synthesized by solid 
phase methods. Their preparation and purification has 
been described elsewhere [12-l 51. 
Solutions were prepared by dissolving the weighed 
peptide in distilled water to obtain concentrations of 
1 to 2 mg/ml. pH adjustments were, after acidification 
to pH 1 with concentrated HCl, effected with minute 
amounts of concentrated NaOH. All spectra were 
recorded on the Jobin-Yvon Dichrograph III model 
using fused quartz cells of 0.5 and 1 .O cm pathlengths. 
Circular dichroism results are expressed in units of 
molar ellipticity [0] . 
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3. Results 
The CD spectrum of angiotensin II in the aromatic 
wavelength region is strongly pH dependent (fig.1). It 
consists at acid and neutral pH of a major band attribut- 
ed to the ’ Lb transition of the tyrosine side chain [ 161, 
centered at 275 nm, and the superposed vibronic 
bands of the phenylalanine side chain transitions at 
268,264, 262,258 and 254 nm. These latter cannot 
be followed independently of the tyrosine signal, as 
they are added on top of the tail of this peak. The 
[19] values at each of these wavelengths reflect only 
the behaviour found for 175 nm. Yet this tyrosine 
side chain signal is greatly affected by the titration. 
At acid pH up to pH 5 the signal at 275 nm is positive 
with an ellipticity of about t200. From pH 5 to pH 8 
the signal intensity decreases, goes through zero and 
becomes negative with values of [e] -240. The 
spectrum changes profoundly between pH 9 and 12 
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Fig.1. CDspectra of Angiotensin II: aromatic region. (---) pH 1.3.’ 
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Fig.2. Ellipticities [0] at 275 nm plotted as a function of pH. 
(-u) Angiotensin II. (+) Ala6 -(A II), (-0-0) DHis6 -(A II). 
(not presented here), giving rise to a strong positive 
band at 293 nm. 
Plotting the ellipticities at 275 nm as a function of 
pH we obtain a titration curve with 3 apparent pK 
values (fig.2). A very small signal variation is observed 
upon titration of the carboxyl group (pK-3.5), 
a second pK at 6.4 suggests he influence of the imida. 
zole side chain of histidine, and the pK at 10 reflects 
the ionization of the tyrosine ring. The spectrum of 
the Ala6 -(A II) analogue (where histidine has been 
replaced by alanine) does not change between pH 4 
and 8, thus confirming the above suggestion, whereas 
the small change in ellipticity during the titration of 
the D-His6 -(A II) analogue (fig.2) hints at the impor- 
tance of the specific spatial orientation of histidine. 
The titration of angiotensin II in aqueous olution by 
’ H NMR has already shown that the tyrosine ortho 
and meta protons are somewhat influenced by the 
deprotonation of the histidine side chain [l] . Although 
the effects are small and ‘3 C-NMR has shown no such 
influence [3], this behaviour has been interpreted in 
terms of conformational changes in the peptide. 
The inversion of the sign observed in the CD spectra 
shows that with increasing pH the tyrosine ring is 
subjected to a new asymetric environment. This might 
arise from its adoption of a different orientation 
367 
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Table 1 
Ellipticites [e] at 275 nm (resp. 261 nm) for angiotensin and several analogues at 
3 pH values. Differences in ellipticity A[01 between pH 4.5 and pH 8.0 
pH 1.0 pH 4.5 pH 8.0 
b] 275 nm A [e-j 
Angiotensin II 
Asn’ - (A II) 
+200 +240 -260 -500 
+100 +150 -280 -430 
-Asp’ -(A II) +180 +100 -320 -420 
Ile”-(A II) +200 +270 -280 -550 
Ala6-(A II) -120 -100 -100 0 
D-His6-(A II) +280 +340 +240 -100 
Pro’-(A II) -110 - 20 -590 -570 
l-6-(A II) + 60 + 60 - 40 -100 
4-8-(A II) +300 +250 -120 --370 
Ala“-(A II) -140 -120 -120 0 
dependent on or independently of the overall peptide 
conformation. In order to distinguish between the 
variations of the tyrosine side chain conformation 
due to spatial interference from histidine and those 
due to changes in the backbone structure, we examined 
a series of analogues with substitutions designed to 
simplify this task. Table 1 gives the spectral parameters 
for these peptides, revealing the following items: (a) 
substitution in position 1 (a frequently used substitu- 
tion for studies of structure-activity relationship) by 
asparagine or by @-coupled aspartic acid does not 
change the spectral titration behaviour. (b) Neither 
does substitution in position 8, replacing phenylalanine 
by isoleucine. This modification, however, simplifies 
the CD spectrum to give the pure tyzosine signal at 
275 nm. (c) On the other hand, for the Ala4-(A 11) 
analogue devoid of tyrosine we found no measurable 
effect of the titration of histidine on the phenylalanine 
signals. (d) Replacement of histidine by alanine in 
368 
position 6 leads to a negative CD signal for tyrosine 
that remains unchanged between pH ? and pH 8. (e) 
The spectrum of the DIG’-(A II) substituted analogue 
remains positive throughout the titration with.only 
a small perturbation by the imidazole deprotonation. 
(f) The N-terminal hexapeptide parallels the behaviour 
of angiotensin II but on a greatly reduced scale. (g) The 
C-terminal pentapeptide 4-8, however, equals the 
titration conduct of the complete peptide. 
Although a correlation of these results <ill have to 
be made with the ones obtained for the peptide region 
[17] , there are certain conclusions that can be drawn 
already. The presence of histidine and its positive 
charge in angiotensin II orients the tyrosine ring in such a 
way as to give rise to a positive CD signal. On the other 
hand, in Pro3-(A II) characterized by a conformation 
tin&r to angiotensin II, even strengthened [ j 81, the 
proline ring forces tyrosine to adopt an orientation 
such as to give a negative signal throughout titration; 
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this orientation, and thus this signal, is much enhanced 
with the pH going from 5 to 8 (table 1). The absence 
of the charged side chain (either after titration or by 
total elimination: Ala6-(A II) ) gives rise to a negative 
tendency of varying degree of the CD signal. As the 
N-terminal hexapeptide (shown to be quite devoid of 
secondary structure [151) indicates, the simple proxi- 
mity of Tyr-X-His alone does not suffice to explain 
the large signal variations observed. In conclusion it 
appears that due to the specific backbone structure 
(primary and secondary) of angiotensin II the orienta- 
tion of the tyrosine side chain, influenced by the speci- 
fically oriented imidazole ring and its positive charge, 
rather than a major conformational change of the 
backbone, is responsible for the observed spectral 
variations. Studies are in progress to determine if these 
phenomena re compatible with any of the proposed 
models of angiotensin II.
References 
[ 11 Glickson, J. D., Cunningham, W. D. and Marshall, G. R. 
(1973) Biochemistry 12, 36843692. 
[2] Weinkam, R. J. and Jorgensen, E. C. (1971) J. Amer. 
Chem. Sot. 93, 7038-7044. 
[3] Zimmer, S., Haar, W., Maurer, W., Rtiterjans, H., 
Fermandjian, S. and Fromageot, P. (1972) Eur. J. 
Biochem. 29.80-87. 
141 Fermandjian, S., Fromageot, P., Tistchenko, A. M., 
Leicknam, J. P. and Lutz, M(1972) Eur. J. Biochem. 28, 
174-182. 
151 
161 
Juliano, L. and Paiva, A. C. M. (1974) Biochemistry 13, 
2445-2450. 
[7] 
181 
]91 
1101 
1111 
1121 
iI31 
iI41 
1151 
Hruby, V. J. (1974) in: Chemistry and Biochemistry of 
Ammo Acids, Peptides and Proteins (Weinstein, B. ed.), 
Vol. 3, pp. 61-66, M. Dekker, New York. 
Regoli, D., Park, W. K. and Rioux, F. (1974) Pharmacol. 
Rev. 26,69-123. 
Marshall, G. R., Bosshard, H. E., Vine, W. V. and Glickson, 
J. D. (1973) Nature New Biol. 245, 125-127. 
Fermandjian, S., Morgat, J. L. and Formageot, P. (1971) 
Eur. J. Biochem. 24,252-258. 
Printz, M. P., Williams, H. P. and Craig, L. C. (1972) 
Proc. Natl. Acad. Sci. U.S.A. 69, 378-382. 
Vine, W. H., Brueckner, D. A., Needleman, P. and Marshall, 
G. R. (1973) Biochemistry 12, 1630-1637. 
Khosla, M. C., Chaturvedi, N. C., Smeby, R. R. and 
Bumpus, F. M. (1968) Biochemistry 7, 3417-3421. 
Seu, J. H., Smeby, R. R. and Bumpus, F. M. (1962) J. 
Amer, Chem. Sot. 84,49484950. 
Khosla, M. C., Kumar, S., Smeby, R. R. and Bumpus, 
F. M. (1972) J. Med. Chem. 15,627-629. 
Greff, D., Fermandjian, S., Fromageot, P., Khosla, M. C., 
Smeby, R. R. and Bumpus, F. M., submitted for publica- 
tion. 
1161 Strickland, E. H. (1974) Crit. Rev. Biochem., 113-175. 
[17] Lintner, K., Fermandjian, S., Fromageot, P., Khosla, M. C., 
Smeby, R. R. and Bumpus, F. M., manuscript in prepara- 
tion. 
1181 Fermandjian, S., Greff, D. and Fromageot, P. (1973) in: 
Dynamic aspects of Confomation Changes in Biological 
Macromolecules (Sadron, C. ed.) pp. 493-509. D. Reidel 
Publ. Comp., Dordrecht-Holland. 
369 
